Intravascular Ultrasound Market Report 2026

The intravascular ultrasound market size has grown strongly in recent years. It will grow from $2.71 billion in 2025 to $2.95 billion in 2026 at a compound annual growth rate (CAGR) of 9%. The growth in the historic period can be attributed to rising prevalence of coronary artery disease, increasing number of percutaneous coronary interventions, limitations of angiography in plaque assessment, growing adoption of stent-based therapies, advancements in catheter-based imaging technologies.

The intravascular ultrasound market size is expected to see strong growth in the next few years. It will grow to $4.13 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing preference for precision-guided cardiology procedures, rising demand for portable and compact ivus systems, growing adoption in peripheral arterial disease diagnosis, expanding investments in advanced cardiac imaging, increasing awareness of ivus clinical benefits. Major trends in the forecast period include growing adoption of ivus-guided coronary interventions, increasing use of ivus for complex lesion assessment, rising demand for real-time intravascular imaging, expansion of minimally invasive cardiac procedures, increasing integration of ivus with cath lab workflows.

The increasing prevalence of cardiovascular diseases (CVDs) is anticipated to drive the growth of the intravascular ultrasound market in the coming years. Cardiovascular diseases (CVDs) encompass a range of disorders that impact the heart and blood vessels. The rise in cardiovascular diseases (CVDs) is attributed to factors such as physical inactivity, unhealthy diet, smoking, chronic stress, and excessive alcohol consumption. Intravascular Ultrasound (IVUS) serves as a crucial diagnostic tool for the management of cardiovascular diseases (CVDs). It delivers detailed images and insights into the interior of blood vessels, particularly the coronary arteries, which can significantly improve the diagnosis, treatment, and management of various cardiovascular conditions. For example, in September 2024, data published by the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, including around 4 million males and 3.6 million females. These diseases account for about 27% of all deaths in the UK, equating to over 170,000 deaths annually, or roughly 480 deaths per day, which is approximately one death every three minutes. Consequently, the growing prevalence of cardiovascular diseases (CVDs) is propelling the expansion of the intravascular ultrasound market.

Major companies operating in the intravascular ultrasound market focus on advancing technology with sonic lumen tomography (SLT) to enhance diagnostic capabilities, support improved decision-making in cardiovascular procedures, and ultimately improve patient outcomes. Sonic lumen tomography (SLT) technology improves visualization of blood vessels by providing high-resolution, cross-sectional images of the lumen (the interior space of a blood vessel) and the vessel walls. For example, in May 2024, Provisio Medical Inc., a US-based medical equipment manufacturer, introduced the Provisio SLT Intravascular Ultrasound (IVUS) system. The Provisio SLT IVUS System includes the SLT IVUS P1 system and the SLT IVUS support crossing catheter. Provisio enhances vessel sizing data acquisition and presentation through Sonic Lumen Tomography technology in front-line support crossing catheters. This solution reduces data acquisition time, minimizes the use of contrast media, and lowers radiation exposure without interrupting the physician's workflow.

In March 2024, Titan Medical Inc., a Canada-based medical technology company, merged with Conavi Medical for an undisclosed amount. The merger aims to establish a leading public company in hybrid intravascular imaging by combining resources to accelerate commercialization. This strategic alliance is intended to expand market reach, strengthen financial capabilities, and support global deployment of advanced imaging technology. Conavi Medical, based in Canada, specializes in the Novasight Hybrid System, which integrates intravascular ultrasound (IVUS) and optical coherence tomography (OCT) for enhanced imaging in cardiovascular procedures.

Major companies operating in the intravascular ultrasound market are Abbott Laboratories, Medtronic plc, Siemens Healthcare GmbH, Fujifilm Corporation, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Fujikura Ltd., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Canon Medical Systems Corporation, ACIST Medical Systems Inc., Pie Medical Imaging BV, Conavi Medical Inc., Samsung Medison Co. Ltd., Esaote S.p.A.

North America was the largest region in the intravascular ultrasound market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravascular ultrasound market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intravascular ultrasound market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the intravascular ultrasound market by increasing the cost of imported electronic components, imaging consoles, and catheter-based systems used in ivus platforms. These impacts are most pronounced in platform-based and advanced modality ivus systems, particularly in north america and europe where reliance on global supply chains is high. Elevated tariffs have raised procurement costs for hospitals and diagnostic centers. However, tariffs are encouraging localized manufacturing, supplier diversification, and innovation in compact and cost-efficient ivus systems, supporting long-term market sustainability.

The intravascular ultrasound market research report is one of a series of new reports that provides intravascular ultrasound market statistics, including intravascular ultrasound industry global market size, regional shares, competitors with a intravascular ultrasound market share, detailed intravascular ultrasound market segments, market trends and opportunities, and any further data you may need to thrive in the intravascular ultrasound industry. This intravascular ultrasound market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Intravascular ultrasound is a medical imaging technique that employs sound waves to capture real-time images of blood vessel walls, helping in the assessment of coronary artery disease and guiding stent placement during procedures. It offers accurate, real-time visualization of arterial structures, improving treatment planning and outcomes in interventional cardiology.

The primary types in the intravascular ultrasound market are platform intravascular ultrasound and compact intravascular ultrasound. Platform refers to the integrated system that includes the IVUS console, imaging software, and user interface, which work together to acquire, process, and display real-time ultrasound images of blood vessels for diagnostic and therapeutic purposes. The different modalities include virtual histology intravascular ultrasound (IVUS), iMap intravascular ultrasound (IVUS), and integrated backscatter intravascular ultrasound (IVUS), with applications in peripheral arterial diseases and cardiovascular diseases. The key end users comprise hospitals, diagnostic centers, and academic and research institutes.

The intravascular ultrasound market consists of revenues earned by entities by providing services such as clinical training, on-site installation, regular maintenance, technical support, data management, image analysis, and clinical and regulatory consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The intravascular ultrasound market also includes sales of Intravascular ultrasound (IVUS) catheters, imaging consoles, ultrasound transducers, guide wires, and pullback devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.